🇺🇸 Zonisamide tablets in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 10

Most-reported reactions

1. Anaemia — 1 report (10%)
2. Blood Glucose Increased — 1 report (10%)
3. Contrast Media Reaction — 1 report (10%)
4. Drug Eruption — 1 report (10%)
5. Eosinophil Count Increased — 1 report (10%)
6. Glycosylated Haemoglobin Increased — 1 report (10%)
7. Monocyte Count Increased — 1 report (10%)
8. Nasopharyngitis — 1 report (10%)
9. Toxic Skin Eruption — 1 report (10%)
10. White Blood Cell Count Decreased — 1 report (10%)

Source database →

Frequently asked questions

Is Zonisamide tablets approved in United States?

Zonisamide tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Zonisamide tablets in United States?

Eisai Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.